# Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers

> **NCT07079930** · PHASE1 · RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Psilocybin and D-Serine
- **DIAGNOSTIC_TEST:** Physical Examination
- **DIAGNOSTIC_TEST:** Vital signs
- **DIAGNOSTIC_TEST:** ECG test
- **DIAGNOSTIC_TEST:** Comprehensive Blood Panel
- **DIAGNOSTIC_TEST:** Complete Blood Count
- **DIAGNOSTIC_TEST:** Urinalysis
- **DIAGNOSTIC_TEST:** Urine Toxicology Screen
- **DIAGNOSTIC_TEST:** A pregnancy Urine test
- **DIAGNOSTIC_TEST:** Electroencephalogram
- **DIAGNOSTIC_TEST:** Plasma Amino Acid Levels
- **DIAGNOSTIC_TEST:** Plasma Inflammation Markers
- **DIAGNOSTIC_TEST:** Plasma Brain-Derived Neurotrophic Facto
- **OTHER:** Mini International Neuropsychiatric Interview
- **OTHER:** Family Psychiatric History Assessment
- **OTHER:** Beck Depression Inventory
- **OTHER:** State-Trait Anxiety Inventory
- **BEHAVIORAL:** Profile of Mood States
- **BEHAVIORAL:** Subjective Units of Distress Scale
- **OTHER:** Five-Dimensional Altered States of Consciousness questionnaire

## Key facts

- **NCT ID:** NCT07079930
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-11
- **Primary completion:** 2026-11
- **Final completion:** 2027-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07079930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07079930, "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07079930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
